Literature DB >> 30227970

Update on Allergen Immunotherapy.

Ralf S Mueller1.   

Abstract

Allergen immunotherapy has been used for many years in dogs and cats and is the only specific treatment of atopic dermatitis that changes the patho-mechanisms of disease by stimulating allergen tolerance. Subcutaneous administration of allergens is the most commonly used administration route, typically in increasing concentrations (induction period) followed by long-term injection of allergen extract (maintenance therapy). Rush protocols with an abbreviated induction period have been reported and shown to be safe in dogs. More recently, oro-mucosal and intralymphatic administration of allergens has been evaluated in dogs. Approximately two-thirds of patients show good to excellent improvement of clinical signs.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergen specific; Canine; Desensitization; Feline; Hyposensitization; Intralymphatic

Mesh:

Year:  2018        PMID: 30227970     DOI: 10.1016/j.cvsm.2018.08.001

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  4 in total

1.  A double-blinded placebo-controlled evaluation of adipose-derived mesenchymal stem cells in treatment of canine atopic dermatitis.

Authors:  Gagandeep Kaur; Ana Ramirez; Chen Xie; David Clark; Charli Dong; Chad Maki; Thomas Ramos; Fari Izadyar; Sandy Oliver Lopez Najera; Jerry Harb; Jijun Hao
Journal:  Vet Res Commun       Date:  2021-10-29       Impact factor: 2.459

Review 2.  Insights Into Mucosal Innate Immune Responses in House Dust Mite-Mediated Allergic Asthma.

Authors:  Arwa Abu Khweek; Eunsoo Kim; Marisa R Joldrichsen; Amal O Amer; Prosper N Boyaka
Journal:  Front Immunol       Date:  2020-12-07       Impact factor: 7.561

3.  Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.

Authors:  Evelien E M Fennis; Catharina M M van Damme; Yvette M Schlotter; Jacqueline D Sinke; Mieke H G Leistra; Richard T Bartels; Femke Broere
Journal:  Vet Dermatol       Date:  2022-05-30       Impact factor: 1.867

4.  Rush immunotherapy in two cats with atopic skin syndrome.

Authors:  Selene Jones; Paul Bloom
Journal:  JFMS Open Rep       Date:  2021-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.